Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C I Smith

Showing results (321-330 of 356) with videos related to

Pageof 36
Sort By:
Oncogene|December 1, 1994
BMX, a novel nonreceptor tyrosine kinase gene of the BTK/ITK/TEC/TXK family located in chromosome Xp22.2L Tamagnone, I Lahtinen, T Mustonen, et al.
Lancet (London, England)|August 28, 1993
Absence of xid mutation in X-linked agammaglobulinaemiaI Vorechovsky, J N Zhou, L Hammarström, et al.
Blood|September 15, 1992
Splice site mutations are a common cause of X-linked chronic granulomatous diseaseM de Boer, B G Bolscher, M C Dinauer, et al.
The EMBO Journal|September 1, 1985
Heterogeneity of T-cell beta-chain gene rearrangements in human leukaemias and lymphomasT H Rabbitts, A Stinson, A Forster, et al.
Biochemical and Biophysical Research Communications|June 11, 1999
Synergistic activation of the human Btk promoter by transcription factors Sp1/3 and PU.1S Müller, A Maas, T C Islam, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1990
Subclass distribution of antigen-specific IgA antibodies in normal donors and individuals with homozygous C alpha 1 or C alpha 2 gene deletionsP E Engström, G Norhagen, A Bottaro, et al.
Human Molecular Genetics|April 1, 1995
Identification of Btk mutations in 20 unrelated patients with X-linked agammaglobulinaemia (XLA)H Jin, A D Webster, M Vihinen, et al.
Clinical and Experimental Immunology|December 1, 1988
The antibody spectrum in individuals with defect expression of HLA class II and the LFA-1 glycoprotein family genesC I Smith, C Bremard-Oury, F Le Deist, et al.
The New England Journal of Medicine|December 22, 1983
Myasthenia gravis after bone-marrow transplantation. Evidence for a donor originC I Smith, J A Aarli, P Biberfeld, et al.
Annals of Internal Medicine|September 1, 1987
Adenine arabinoside monophosphate (vidarabine phosphate) in combination with human leukocyte interferon in the treatment of chronic hepatitis B. A randomized, double-blinded, placebo-controlled trialG Garcia, C I Smith, J I Weissberg, et al.
Pageof 36

Showing results (321-330 of 356) with videos related to

Sort By:
Pageof 36
Oncogene|December 1, 1994
BMX, a novel nonreceptor tyrosine kinase gene of the BTK/ITK/TEC/TXK family located in chromosome Xp22.2L Tamagnone, I Lahtinen, T Mustonen, et al.
Lancet (London, England)|August 28, 1993
Absence of xid mutation in X-linked agammaglobulinaemiaI Vorechovsky, J N Zhou, L Hammarström, et al.
Blood|September 15, 1992
Splice site mutations are a common cause of X-linked chronic granulomatous diseaseM de Boer, B G Bolscher, M C Dinauer, et al.
The EMBO Journal|September 1, 1985
Heterogeneity of T-cell beta-chain gene rearrangements in human leukaemias and lymphomasT H Rabbitts, A Stinson, A Forster, et al.
Biochemical and Biophysical Research Communications|June 11, 1999
Synergistic activation of the human Btk promoter by transcription factors Sp1/3 and PU.1S Müller, A Maas, T C Islam, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1990
Subclass distribution of antigen-specific IgA antibodies in normal donors and individuals with homozygous C alpha 1 or C alpha 2 gene deletionsP E Engström, G Norhagen, A Bottaro, et al.
Human Molecular Genetics|April 1, 1995
Identification of Btk mutations in 20 unrelated patients with X-linked agammaglobulinaemia (XLA)H Jin, A D Webster, M Vihinen, et al.
Clinical and Experimental Immunology|December 1, 1988
The antibody spectrum in individuals with defect expression of HLA class II and the LFA-1 glycoprotein family genesC I Smith, C Bremard-Oury, F Le Deist, et al.
The New England Journal of Medicine|December 22, 1983
Myasthenia gravis after bone-marrow transplantation. Evidence for a donor originC I Smith, J A Aarli, P Biberfeld, et al.
Annals of Internal Medicine|September 1, 1987
Adenine arabinoside monophosphate (vidarabine phosphate) in combination with human leukocyte interferon in the treatment of chronic hepatitis B. A randomized, double-blinded, placebo-controlled trialG Garcia, C I Smith, J I Weissberg, et al.
Pageof 36